跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MCS-5
首页
药物
MCS-5
MCS-5
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Nucleic acid sequence segment for enhancing protein expression
US 9550983 B2
申请人: UNIV CHINA MEDICAL
优先权: 2015
US
Nucleic acid vector
US 10626413 B2
申请人: DING ENYU
优先权: 2016
US
Method for inhibiting proliferation of extracellular matrix of diabetic nephropathy by kidney maintaining pills
CN 109745457 A
申请人: MA BAOHUA
优先权: 2017
CN
Dual target CAR-T therapy vector for lung cancer and construction method and application of dual target CAR-T therapy vector
CN 108659133 A
申请人: SHANGHAI YIHAO BIOTECHNOLOGY CO LTD
优先权: 2018
CN
Dual-target CAR-T therapeutic vector for breast cancer and construction method and application thereof
CN 108864288 A
申请人: SHANGHAI YIHAO BIOTECHNOLOGY CO LTD
优先权: 2018
CN
Double-target CAR-T therapy vector for liver cancer, as well as construction method and application thereof
CN 108641000 A
申请人: SHANGHAI YIHAO BIOTECHNOLOGY CO LTD
优先权: 2018
CN
Double-target-point CAR-T (Chimeric Antigen Receptor T) treatment vector for gastric cancer, construction method and application thereof
CN 108864289 A
申请人: SHANGHAI YIHAO BIOTECHNOLOGY CO LTD
优先权: 2018
CN
Double-target CAR-T therapy vector for colon cancer, and construction method and application of double-target CAR-T therapy vector
CN 108641001 A
申请人: SHANGHAI YIHAO BIOTECHNOLOGY CO LTD
优先权: 2018
CN
一种人-15-羟基前列腺素脱氢酶过表达质粒的构建方法及其应用
CN 109182365 B
申请人: 南京医科大学
优先权: 2018
CN
AQP5重组过表达载体及其构建方法和用途
CN 109321601 B
申请人: 汉恒生物科技(上海)有限公司
优先权: 2018
CN
第 1 / 2 页
上一页
下一页
药物
反馈